Coherus BioSciences, Inc. logo
Coherus BioSciences Re-Submits Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate)
May 03, 2018 09:16 ET | Coherus BioSciences, Inc.
REDWOOD CITY, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (NASDAQ:CHRS), today announced the re-submission of its biologics license application (BLA) for CHS-1701, a...
LISTING OF MINI FUTU
LISTING OF MINI FUTURES ISSUED BY NORDEA BANK AB (PUBL)
May 03, 2018 09:16 ET | Nasdaq Stockholm AB
NOTICE 2018-05-03 MINI FUTURES LISTING OF MINI FUTURES ISSUED BY NORDEA BANK AB (PUBL) Nasdaq Stockholm has decided to list 42 warrants issued by Nordea Bank AB (publ) with effect from...
20180109-ogr_200.jpg
Osisko Declares 15th Consecutive Quarterly Dividend
May 03, 2018 09:15 ET | Osisko Gold Royalties Ltd.
MONTREAL, May 03, 2018 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd ("Osisko" or the "Company") (TSX:OR) (NYSE:OR) is pleased to announce a second quarter 2018 dividend of $0.05 per common share....
Osisko déclare un 15
Osisko déclare un 15e dividende trimestriel consécutif
May 03, 2018 09:15 ET | Redevances Aurifères Osisko Ltée
MONTRÉAL, 03 mai 2018 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (« Osisko » ou la « Société ») (TSX:OR) (NYSE:OR) a le plaisir d’annoncer un dividende pour le deuxième trimestre de...
Listing of bond loan
Listing of bond loan(s) issued by Vattenfall AB on STO Corporate Bonds (251/18)
May 03, 2018 09:15 ET | Nasdaq Stockholm AB
Nasdaq Stockholm decides to officially list 1 bond loan(s) issued by Vattenfall AB with effect from 2018-05-04. Last day of trading is set to 2022-10-24. The instrument(s) will be listed on STO...
Amarantus.png
MANF Therapeutics Announces Issuance of Patent in Hong Kong Covering Use of MANF for Treatment of Diabetes and Wolfram's
May 03, 2018 09:15 ET | Amarantus Bioscience Holdings, Inc.
NEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – MANF Therapeutics, Inc., a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc. (OTCPK:AMBS) in pre-clinical development...
Transaction in Own Shares and Total Voting Rights and Capital
May 03, 2018 09:13 ET | Albion Development VCT PLC - Ordinary Shares
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ALBION DEVELOPMENT VCT PLC LEI Code...
Osisko_RAO-logo_color.jpg
Osisko publie ses résultats pour le premier trimestre de 2018
May 03, 2018 09:12 ET | Redevances Aurifères Osisko Ltée
MONTRÉAL, 03 mai 2018 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (la « Société » ou « Osisko ») (TSX:OR) (NYSE:OR) annonce aujourd’hui ses résultats financiers consolidés pour le...
20180109-ogr_200.jpg
Osisko Reports First Quarter 2018 Results
May 03, 2018 09:12 ET | Osisko Gold Royalties Ltd.
MONTREAL, May 03, 2018 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Company” or “Osisko”) (TSX:OR) (NYSE:OR) today announced its consolidated financial results for the first quarter ended...
Transaction in Own Shares and Total Voting Rights and Capital body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ALBION TECHNOLOGY & GENERAL VCT PLC LEI Code...